Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study on the Reduced Intravenous Fluids to Improve Clearance of High-Dose Methotrexate (HDMTX) in Children With Lymphoma or Acute Lymphoblastic Leukemia

NCT03964259 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT03964259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03964259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study on the Reduced Intravenous Fluids to Improve Clearance of High-Dose Methotrexate (HDMTX) in Children With Lymphoma or Acute Lymphoblastic Leukemia
Lead sponsor
Virginia Commonwealth University
Phase
Phase 1
Overall status
Completed
Start date
October 2, 2019
Completion date
December 28, 2022
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, lymphoma, pediatric all, pediatric cancer, pediatric lymphoma